| 臺大學術典藏 |
2021-04-29T00:48:10Z |
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature
|
Frezza A.M.; Ravi V.; Lo Vullo S.; Vincenzi B.; Tolomeo F.; WEI-WU CHEN; Teterycz P.; Baldi G.G.; Italiano A.; Penel N.; Brunello A.; Duffaud F.; Hindi N.; Iwata S.; Smrke A.; Fedenko A.; Gelderblom H.; Van Der Graaf W.; Vozy A.; Connolly E.; Grassi M.; Benjamin R.S.; Broto J.-M.; Grignani G.; Jones R.L.; Kawai A.; Tysarowski A.; Mariani L.; Casali P.G.; Stacchiotti S. |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy
|
Su T.-H.; Hsu S.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-14T23:18:41Z |
Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy
|
TUNG-HUNG SU; Hsu, Shih Jer; JIA-HORNG KAO |
| 國立臺灣大學 |
2008-04 |
Systemic therapy for metastatic urothelial carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Pu, Yeong-Shiau; Vogelzang, Nicholas J. |
| 國立臺灣大學 |
2008 |
Systemic Therapy for Metastatic Urothelial Carcinoma
|
林家齊; 徐志宏; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; PU, YEONG-SHIAU |
| 臺大學術典藏 |
2020-05-25T07:35:32Z |
Systemic therapy for metastatic urothelial carcinoma
|
Chia-Chi Lin; Hsu C.-H; Pu Y.-S; Vogelzang N.J. |
| 臺大學術典藏 |
2021-02-02T00:46:53Z |
Systemic therapy for metastatic urothelial carcinoma
|
Lin C.-C.; Hsu C.-H.; YEONG-SHIAU PU; Vogelzang N.J. |
| 臺大學術典藏 |
2022-09-15T01:09:52Z |
Systemic therapy for metastatic urothelial carcinoma
|
Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.; Vogelzang N.J. |
| 國家衛生研究院 |
2022-09 |
Systemic treatment of advanced unresectable hepatocellular carcinoma after first-line therapy: Expert recommendations from Hong Kong, Singapore, and Taiwan
|
Yau, T;Tai, D;Chan, SL;Huang, YH;Choo, SP;Hsu, C;Cheung, TT;Lin, SM;Yong, WP;Lee, J;Leung, T;Shum, T;Yeung, CSY;Tai, AY;Law, ALY;Cheng, AL;Chen, LT |
| 臺大學術典藏 |
2021-03-10T02:36:32Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
Chen T.W.-W.;Jan I.-S.;Chang D.-Y.;Lin C.-H.;Chen I.-C.;Chen H.-M.;Cheng A.-L.;Yen-Shen Lu; Chen T.W.-W.; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; YEN-SHEN LU |
| 臺大學術典藏 |
2021-03-12T00:50:51Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
Chen T.W.-W.; I-SHIOW JAN; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-03-15T06:27:30Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
Chen T.W.-W.; Jan I.-S.; DWANG-YING CHANG; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-16T03:26:35Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
Chen T.W.-W.; Jan I.-S.; Chang D.-Y.; Lin C.-H.; I-CHUN CHEN; Chen H.-M.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:17Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
Chen T.W.-W.; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2022-03-15T05:39:20Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
WEI-WU CHEN; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-03-18T03:23:29Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
WEI-WU CHEN; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S. |
| 國家衛生研究院 |
1998-08 |
Systemic treatment of neoplastic conditions with retinoids
|
Hsu, MC |
| 國家衛生研究院 |
2023-12-31 |
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation
|
Su, YY;Chiang, NJ;Chiu, TJ;Huang, CJ;Hsu, SJ;Lin, HC;Yang, SH;Yang, Y;Chou, WC;Chen, YY;Bai, LY;Li, CP;Chen, JS |
| 國立成功大學 |
2024-06 |
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation
|
Su;Yung-Yeh;Chiang;Nai-Jung;Chiu;Tai-Jan;Huang;Chien-Jui;Hsu;Shao-Jung;Lin;Hsin-Chen;Yang;Shih-Hung;Yang;Youngsen;Chou;Wen-Chi;Chen;Yen-Yang;Bai;Li-Yuan;Li;Chung-Pin;Chen;Jen-Shi |
| 臺大學術典藏 |
2021-08-05T02:41:53Z |
Systemically delivered antibody-labeled magnetic iron oxide nanoparticles are less toxic than plain nanoparticles when activated by alternating magnetic fields
|
Yang C.-T;Korangath P;Stewart J;Hu C;Fu W;Gr?ttner C;Beck S.E;Lin F.-H;Ivkov R.; Yang C.-T; Korangath P; Stewart J; Hu C; Fu W; Gr?ttner C; Beck S.E; Lin F.-H; Ivkov R.; FENG-HUEI LIN |
| 嘉南藥理大學 |
2009 |
Systems & Control Letters
|
Elsevier SDOL |
| 國立臺灣大學 |
1989 |
Systems Analysis of Tanshui River Basin
|
郭振泰; Chu, W. S.; Hsu, H. H.; 吳建民; Kuo, Jan-Tai; Chu, W. S.; Hsu, H. H.; Wu, Chien-Min |
| 國立臺灣大學 |
2008 |
Systems analysis reveals the differentiation mechanism of leukemia cells to macrophages induced by ganoderma lucidum polysaccharides
|
Hsu, J.-W.; Huang, H.-C; Juan, H.-F. |
| 臺大學術典藏 |
2020-03-06T03:41:53Z |
Systems Analysts' Attitudes Toward Information Systems Development
|
Jiang J.J.;Klein G.;Balloun J.L.; Jiang J.J.; Klein G.; Balloun J.L.; JIUNN-YIH JIANG |
| 淡江大學 |
2012-01-31 |
Systems and methods for interference prediction
|
楊淳良; Yang, Chun-liang; 徐達儒; Hsu, Dar-zu |
